Reta-Peptide
Finnrick has tested 178 samples from Reta-Peptide across 10 products.
Finnrick Vendor Profile
to
Reta-Peptide
Tracking 10 products
178 total samples tested
Last test 5 May 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Cagrilintide | 3 | 1 Jul 2025 | 4 Sep 2025 | |||||
| Ipamorelin | 10 | 24 Jul 2025 | 18 Mar 2026 | |||||
| GHK-Cu | 21 | 16 Jul 2025 | 5 May 2026 | |||||
| PT-141 | 5 | 31 Aug 2025 | 15 Jan 2026 | |||||
| Tirzepatide | 27 | 20 Jun 2025 | 28 Apr 2026 | |||||
| Tesamorelin | 13 | 9 Sep 2025 | 27 Apr 2026 | |||||
| BPC-157 | 14 | 16 Jul 2025 | 28 Apr 2026 | |||||
| CJC-1295 | 7 | 24 Jul 2025 | 6 Mar 2026 | |||||
| Retatrutide | 67 | 20 Jun 2025 | 28 Apr 2026 | |||||
| TB-500 | 10 | 24 Jul 2025 | 29 Mar 2026 | |||||
The Reta-Peptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.7
Based on 37 overall satisfaction reports
Ease of Purchase4.7(37)
Payment Methods4.5(37)
Delivery Speed4.5(37)
Packaging Quality4.8(36)
Customer Service4.7(21)
People who submitted test requests to Finnrick gave Reta-Peptide an average satisfaction rating of 4.7 out of 5 across 37 reports associated with samples received and tested by Finnrick.
Most recent Reta-Peptide tests
Samples are tested in commercial labs
178
tests
10
products
Scores
AVGMINMAX
First
20 Jun 2025
Last
5 May 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 5 May 2026 | GHK-Cu | View | 100mg | 99.9mg | -0.1% | 99.90% | n/a | Feb 1, 2026 | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 28 Apr 2026 | GHK-Cu | View | 50mg | 51.2mg | +2.4% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 28 Apr 2026 | Tirzepatide | View | 50mg | 50.2mg | +0.4% | 99.90% | n/a | 1/2/26 | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 28 Apr 2026 | BPC-157 | View | 10mg | 2.86mg | -71.4% | 38.20% | low | Jan 3, 2026 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 10mg | 8.22mg | -17.8% | 99.30% | below LOQ | Feb 1, 2026 | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 27 Apr 2026 | Tesamorelin | View | 10mg | 11.1mg | +11.0% | 99.70% | n/a | JAN 31, 2026 | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 27 Apr 2026 | Retatrutide | View | 60mg | 61.4mg | +2.3% | 99.80% | n/a | March 6 2026 | No Label / Copper Crimp / Clear Cap | Lab G | Public | |